Atherectomy is a minimally invasive surgical procedure that clears plaque blockages from coronary and peripheral veins. The increase in atherectomy treatments is primarily caused by the persistent rise in the prevalence of arterial blockages, which is especially aided by the aging population and cardiovascular disorders.
The market worth of atherectomy devices in 2021 was USD 1.02 billion, and it will be worth USD 2.01 billion by 2030, growing at a 7.34% CAGR during the forecast period.
The market for atherectomy devices is rising as a result of a number of causes, including an aging population, an increase in cardiovascular disease prevalence, an increase in the prevalence of lifestyle diseases, including diabetes and hypertension, and product development innovation.
The primary reasons propelling the market’s expansion include the increased prevalence of peripheral artery disease (PAD), atherosclerosis, diabetes, and obesity, as well as the rising elderly population worldwide. A good outlook for the market is also being created by the increased desire for MI atherectomy surgical treatments among patients and healthcare professionals. Infection risks are decreased, there is less pain and trauma during surgery, and the patient recovers more quickly thanks to these gadgets. Other growth-promoting elements include a variety of commercial breakthroughs, such as the creation of drug-coated balloons (DCB).
Patients choose alternate forms of treatment because of the high cost of atherectomy. An NCBI study found that the typical angioplasty expense is roughly USD 7300. Atherectomy, on the other hand, typically costs USD 9300. The demand for atherectomy is impacted by the high expenses, which hinders the market’s expansion.
The industry growth can be expedited to create more growth prospects with newer and better atherectomy devices. Atherectomy devices might be improved through procedures like percutaneous revascularization, which make use of interventional radiology and optical coherence tomography as therapeutic philosophies. Additionally, thrombectomy and vitrectomy methods for atherectomy can be employed.
The market is segmented into orbital atherectomy, rotational atherectomy, directional coronary atherectomy, and laser atherectomy.
With roughly 30% of the market, the orbital atherectomies category had the highest size in 2020. A further approach for lesion preparation of calcified plaque is orbital atherectomy. In order to prevent peripheral and coronary percutaneous endovascular interventions, this is done. The American Heart Association published a study that found that orbital atherectomy had a 99% success rate.
The market for laser atherectomy will expand at the fastest rate, with a CAGR of 7%, because of the technology’s suitability for the clinical advantages it offers and the ongoing advancements in directed atherectomies.
In terms of application, the market is segmented into cardiovascular applications, peripheral vascular applications, and neurovascular applications.
The peripheral vascular application will expand at a rapid rate, with the highest CAGR of 6.71% during the forecast period. It is due to the rising adoption of atherectomy as a treatment for peripheral vascular and cardiac illnesses.
On the basis of end-user, the market is segmented into ambulatory care centers, hospitals & surgical centers, and others.
Hospital and surgical centers will register maximum revenue share during the forecast period, with the largest CAGR of 6.63%. It is mainly due to a significant rise in Atherectomy acceptability for the treatment of cardiac and peripheral vascular diseases.
With a share of 75.83%, North America had the largest market. The industry has expanded as a result of better technology, more atherectomy-trained medical practitioners, and an increase in peripheral, cardiovascular, and neurovascular illnesses. The CDC estimates that 6.5 million Americans aged 40 and older have peripheral vascular disease. With a CAGR of 8.2%, Asia-Pacific will experience the most industry growth between 2020 and 2030. Target diseases have increased as a result of socioeconomic changes, poor diet, alcohol consumption, smoking, and demographic aging, which has also boosted demand for the industry as a whole. 4.77 million Indians will suffer cardiovascular disorders in 2020, according to an NCBI study.
- Rex Medical
- Avinger, Inc.
- Koninklijke Philips N.V.
- Becton, Dickinson, and Company
- Boston Scientific Corporation
- Abbott Laboratories
The market worth of atherectomy devices in 2021 was USD 1.02 billion, and it will be worth USD 2.01 billion by 2030, growing at a 7.34% CAGR during the forecast period. The market for atherectom devices is expanding as a result of the rising prevalence of illnesses like Coronary Artery disease (CAD), and Peripheral Artery disease (PAD) caused by risk factors and comorbidities, including diabetes, hypertension, and obesity.
Green Hydrogen Market Report – The global green hydrogen market will witness a robust CAGR of 55.1%, valued at $1.45 billion in 2021, expected to appreciate and reach $75.72 billion by 2030, confirms Strategic Market Research. Europe had the highest share of the worldwide green hydrogen market, with more than 57%.